Fludara and Pulmonary function test abnormal - a phase IV clinical study of FDA data

Summary:

Pulmonary function test abnormal is reported as a side effect among people who take Fludara (fludarabine phosphate), especially for people who are male, 50-59 old, also take Thalidomide, and have Juvenile rheumatoid arthritis.

The phase IV clinical study analyzes which people have Pulmonary function test abnormal when taking Fludara. It is created by eHealthMe based on reports of 46,669 people who have side effects when taking Fludara from the FDA, and is updated regularly.

What is Fludara?

Fludara has active ingredients of fludarabine phosphate. eHealthMe is studying from 46,686 Fludara users. Check the latest studies of Fludara.

What is Pulmonary function test abnormal?

Pulmonary function test abnormal is found to be associated with 296 drugs and 320 conditions by eHealthMe. Check the latest studies of Pulmonary function test abnormal.

On Aug, 04, 2026

46,669 people reported to have side effects when taking Fludara.
Among them, 11 people (0.02%) have Pulmonary function test abnormal.

Could Fludara cause Pulmonary function test abnormal?

Among these 11 people:

What is the gender of people who have Pulmonary function test abnormal when taking Fludara? *

female: 42.86 %
male: 57.14 %

What is the age of people who have Pulmonary function test abnormal when taking Fludara? *

What are other drugs people take besides Fludara? *

What are other side effects people have besides Pulmonary function test abnormal? *

Inflammation: 9 people, 81.82%
High Blood Pressure: 8 people, 72.73%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 7 people, 63.64%
Herpes Zoster: 7 people, 63.64%
Focal Nodular Hyperplasia (tumour of the liver): 7 people, 63.64%
Growth Retardation (delayed growth): 7 people, 63.64%
Clostridium Difficile Colitis (inflammation of colon by clostridium difficile bacteria infection): 7 people, 63.64%
Joint Effusion (presence of extra fluid in joint covering): 7 people, 63.64%
Chronic Thyroiditis (long lasting inflammation of thyroid gland): 7 people, 63.64%
Cellulitis Staphylococcal (a type of bacteria originated skin soft tissue infection): 7 people, 63.64%

What are the existing conditions these people have? *

Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 7 people, 63.64%
Bone Marrow Conditioning Regimen: 5 people, 45.45%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 3 people, 27.27%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Fludara and have Pulmonary function test abnormal?

- Check whether Pulmonary function test abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fludara:

Fludara (46,686 reports)

Browse all side effects of Fludara:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pulmonary function test abnormal:

Pulmonary function test abnormal (296 drugs)

Browse all the conditions that are associated with Pulmonary function test abnormal:

Pulmonary function test abnormal (320 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fludarabine phosphate (the active ingredients of Fludara) and Fludara (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.